Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
DXDE5N
|
||||
Drug Name |
4-(3-phenyl-3H-[1,2,3]triazolo[4,5-d]pyrimidin-5-ylamino)benzoic acid
|
||||
Synonyms |
CHEMBL402932
|
||||
Indication | Discovery agent | Investigative | [1587926] | ||
Formula |
C17H12N6O2
|
||||
Canonical SMILES |
OC(=O)c1ccc(Nc2ncc3nnn(c4ccccc4)c3n2)cc1
|
||||
InChI |
InChI=1S/C17H12N6O2/c24-16(25)11-6-8-12(9-7-11)19-17-18-10-14-15(20-17)23(22-21-14)13-4-2-1-3-5-13/h1-10H,(H,24,25)(H,18,19,20)
|
||||
InChIKey |
SRUYEOQJIXGTDT-UHFFFAOYSA-N
|
||||
Target and Pathway | |||||
Target(s) | Aurora kinase A | Target Info | [1587926] | ||
Glycogen synthase kinase-3 | Target Info | [1587926] | |||
KEGG Pathway | Oocyte meiosis | ||||
NetPath Pathway | TGF_beta_Receptor Signaling Pathway | ||||
Pathway Interaction Database | Aurora B signaling | ||||
Signaling by Aurora kinases | |||||
Integrin-linked kinase signaling | |||||
PLK1 signaling events | |||||
Aurora A signalingbetacatenin_deg_pathway:Degradation of beta catenin | |||||
Canonical Wnt signaling pathway | |||||
FOXM1 transcription factor network | |||||
Class I PI3K signaling events mediated by Akt | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.